MYRANDA GLANT: Open Payments
NPI 1275121261 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 14 payments from 10 companies in 2025. Trend: 2023 $657 · 2024 $740 · 2025 $421
Food & beverage: $353Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $69 |
| Astellas Pharma US Inc | 1 | $68 |
| UROGEN PHARMA, INC. | 2 | $50 |
| Boston Scientific Corporation | 1 | $47 |
| Teleflex LLC | 2 | $47 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $27 |
| COLOPLAST CORP | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: RYBREVANT, JELMYTO, Axonics, BOTOX, PYLARIFY, UROLIFT, PureWick Female External Catheter, BARRIGEL.
Industry payments across IN — which companies pay providers there.
